SCHEMBL1665038

SCHEMBL1665038

NC1CCN(c2ccc(Nc3ccc4c(cnn4-c4ccc(NC(=O)c5cccs5)cc4)c3)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.49
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NAMPT P43490 1/20 0.42
LMNA P02545 1/20 0.41
MAPK8 P45983 3/20 0.40
MAPK10 P53779 3/20 0.40
MAPK14 Q16539 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665044 0.93 MAPT (0.48) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1664235 0.91 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1666799 0.89 MAPT (0.53) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1664587 0.88 MAPT (0.48) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1666114 0.87 MAPT (0.51) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1666916 0.86 MAPT (0.52) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1664395 0.86 MAPT (0.50) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL6125796 0.86 MAPT (0.50) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1664696 0.85 MCHR1 (0.52) MAPTRAB9ANPC1SMN1; SMN2POLB
SCHEMBL1664237 0.84 MAPT (0.49) MAPTRAB9ANPC1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed